Starpharma Holdings Limited (SPHRF) AI Stock Analysis

Starpharma Holdings Limited

(Other OTC:SPHRF)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Debt ReductionMaterial debt reduction lowers financial risk and reduces the burden of interest and refinancing obligations. This gives Starpharma greater resilience while it develops its dendrimer-based products, although continued losses mean the balance-sheet benefit must be preserved.

Negative Factors

Persistent LossesSustained operating and net losses show that Starpharma has not yet established a self-sustaining earnings model. Continued losses can consume capital, restrict investment flexibility, and make future progress dependent on achieving stronger revenue scale or materially improving operating costs.

Starpharma Holdings Limited (SPHRF) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $158.31M
Dividend Yield: ―
Average Volume (3M): 437
Price to Earnings (P/E): -26.3
Beta (1Y): 0.40
Revenue Growth: 151.19%
EPS Growth: 18.54%
Country: US
Employees: 50
Sector: Healthcare
Sector Strength: 51
Industry: Biotechnology

Starpharma Holdings Limited Business Overview & Revenue Model

Company Description

Starpharma Holdings Limited is a biopharmaceutical enterprise focused on the research, development, and global commercialization of dendrimer-based products for the pharmaceutical, life sciences, and other industries. Its current offerings include Vi...

Starpharma Holdings Limited Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

SPHRF against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
AU:RCE	46Neutral	AUD 110.10M	-6.95	84.67%	―	―	42.51%
AU:DXB	44Neutral	AUD 126.08M	-4.22	362.74%	―	-22.13%	-108.82%
AU:BOT	41Neutral	AUD 27.63M	-0.31	-118.74%	―	499.47%	31.20%
AU:ADO	38Underperform	AUD 52.24M	-11.43	-77.75%	―	-51.74%	24.00%
AU:IMM	38Underperform	AUD 33.90M	-0.43	-98.86%	―	―	-27.73%

* Healthcare Sector Average

Performance Comparison

SPHRF and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
SPHRF	Starpharma Holdings Limited	0.33	0.17	105.70%
AU:IMM	Immutep Ltd	0.02	-0.26	-91.79%
AU:DXB	Dimerix Limited	0.21	-0.29	-58.00%
AU:ADO	AnteoTech Ltd	0.02	-0.00	-5.88%
AU:BOT	Botanix Pharmaceuticals Limited	0.01	-0.12	-92.31%
AU:RCE	Recce Pharmaceuticals Ltd.	0.36	-0.04	-10.00%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Starpharma Holdings Limited AI Stock Analysis